Japan Digital Therapeutics for Diabetes Market is expected to reach US$ 136.44 Million by 2033 | Top key players - Welldoc, Inc., Omada Health Inc., Glooko, Inc.

Market Size and Forecast:

The Japan Digital Therapeutics for Diabetes Market Size reached US$ 56.59 million in 2024 and is expected to reach US$ 136.44 million by 2033, growing at a CAGR of 10.4% during the forecast period 2025-2033.

The Japan Digital Therapeutics for Diabetes Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/japan-digital-therapeutics-for-diabetes-market?sz

The Japan Digital Therapeutics for Diabetes Market encompasses software-driven medical interventions designed to prevent, manage, or treat diabetes through personalized digital solutions. These include mobile apps, wearable devices, and telehealth platforms that support glucose monitoring, lifestyle modification, and medication adherence. Growing diabetes prevalence, rising smartphone adoption, and government healthcare initiatives drive market growth in Japan.

Industry Recent Developments:

United States:

✅ July 2025: Omada Health launched a digital therapeutics program integrating AI-driven lifestyle coaching for diabetes management, offering personalized recommendations and glucose monitoring to improve glycemic control and overall health.

✅ July 2025: Dexcom received FDA approval for its G7 continuous glucose monitoring device, which has the longest wear period of 15 days and provides enhanced user convenience and diabetic control.

✅ September 2025: Abbott announced a strategic partnership with Dexcom to co-develop next-generation diabetes management devices, focusing on innovation in continuous glucose monitoring and mobile app integration.

Japan:

✅ August 2025: Japan's digital therapeutics market for diabetes is projected to grow significantly from USD 56.6 million in 2024 to USD 136.4 million by 2033, driven by software-led personalization and aging demographics.

✅ August 2025: As of April 2025, Japan had five digital therapeutics products approved, with two covered by national health insurance, demonstrating government support and regulatory progress for digital diabetes management solutions.

✅ October 2025: The Japanese market continues to see increased integration of AI-driven personalization in digital therapeutics apps, combined with wearable devices for continuous glucose monitoring and insulin delivery, aiding remote and elderly patient care.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/japan-digital-therapeutics-for-diabetes-market?sz

Major Key Players:

Welldoc, Inc.
Omada Health Inc.
Glooko, Inc.
Azumio Inc.
Abbott Laboratories
Life Log Technology, Inc.
Dexcom, Inc.
Health2Sync
iHealth Labs Inc.
Medtronic plc.

Key Growth Drivers:

The rising prevalence of diabetes in Japan, particularly among the aging population (29% aged 65 or older), which increases demand for effective chronic disease management solutions.

The adoption of digital solutions such as mobile apps, wearable devices (e.g., continuous glucose monitors), and AI-driven platforms that provide remote monitoring, personalized feedback, and real-time diabetes management, reducing the need for frequent clinic visits.

Strong government support including reimbursement policies, regulatory clarity, and initiatives promoting healthcare digitization that encourage adoption of digital therapeutics as cost-effective and scalable alternatives to traditional diabetes care methods.

Segments Covered in the Japan Digital Therapeutics for Diabetes Market:

By Product Type: Software Solutions, Hardware Solutions.

By Application: Type-1 Diabetes, Type-2 Diabetes, Pre-Diabetes.

By End-User: Hospitals, Specialty Clinics, Homecare Settings, Others.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=japan-digital-therapeutics-for-diabetes-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Japan Digital Therapeutics for Diabetes market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Japan Digital Therapeutics for Diabetes Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Japan Digital Therapeutics for Diabetes market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Japan Digital Therapeutics for Diabetes Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Japan Digital Therapeutics for Diabetes Market in 2025?
◆ What is the projected growth rate of the Japan Digital Therapeutics for Diabetes Market through 2033?
◆ Who are the key players in the Japan Digital Therapeutics for Diabetes Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.